Dosecann is a wholly owned subsidary of the Auxly Cannabis Group and is a holder of a Processing Licence and Analytical Testing Licence pursuant to the Cannabis Act. Dosecann hosts 42,000 square feet of space dedicated to extraction, quality testing, research and development, product formulation and manufacturing. The facility will serve as the hub for Auxly and its partners to develop and manufacture higher margin, value-added cannabis products for the medical and adult-use markets.
In conversation with Tina Woollard, Chief Scientific Officer
Q:What does Dosecann do?
A:Our state of the art facilities comprise extraction, manufacturing and research. We’re focused on developing innovative products not only in the medical space, but for recreational use as well. With a strong background in pharmaceuticals, safety and quality drives all of our decisions. Instead of struggling to meet the bar of certain regulatory requirements, we’re already there. We’re setting the industry standard for safe, high quality products.
Q:What does Auxly offer its partners?
A:Working with the Auxly team, we gain access to a wider range of knowledge and experience. They’re actively building a business with a culture of openness, innovation and consideration, and it shows in the work that they do.